Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients

The Montreal Cognitive Assessment to Screen for Cognitive Impairment in HIV Patients Older Than 60 Years

(2014) Benedetta Milanini et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Simple and Complex Rule Induction Performance in Young and Older Adults: Contribution of Episodic Memory and Working Memory

(2014) Joukje M. Oosterman et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS

(2013) Amy R. Zipursky et al.   AIDS

A case-control pilot study on cognitive functioning, symptom validity and psychological wellbeing in HIV-1-infected patients in the Netherlands

(2013) M A M Janssen et al.   INTERNATIONAL JOURNAL OF STD & AIDS

The Alzheimer’s disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons

(2013) Edgar Turner Overton et al.   JOURNAL OF NEUROVIROLOGY

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?

(2011) Magnus Gisslén et al.   BMC INFECTIOUS DISEASES

Screening for Cognitive Impairment in Human Immunodeficiency Virus

(2011) V. Valcour et al.   CLINICAL INFECTIOUS DISEASES

Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment*

(2011) L Koski et al.   HIV MEDICINE

Screening utility of the Montreal Cognitive Assessment (MoCA): in place of – or as well as – the MMSE?

(2011) A. J. Larner   INTERNATIONAL PSYCHOGERIATRICS

Construct Validity of the Montreal Cognitive Assessment (MoCA)

(2011) Sandra Freitas et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease

(2010) Aleksandar Videnovic et al.   MOVEMENT DISORDERS

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

(2010) R. K. Heaton et al.   NEUROLOGY